Navigation Links
Corrected Press Release: Kensey Nash to Present at the Bank of America 2008 Health Care Conference
Date:5/12/2008

[Corrects and revises Press Release from May 1st, 2008. Correction limited

to the time of presentation.]

EXTON, Pa., May 12 /PRNewswire-FirstCall/ -- Kensey Nash Corporation (Nasdaq: KNSY) is scheduled to present at the Bank of America 2008 Health Care Conference at The Four Seasons Hotel in Las Vegas, on Tuesday, May 13, 2008.

Joseph W. Kaufmann, Kensey Nash's President & CEO, will deliver the Company's presentation, beginning at approximately 4:20 p.m. (ET). To hear the live webcast of the Kensey Nash presentation at the Bank of America conference, go to http://www.veracast.com/webcasts/bas/healthcare08/id13108295.cfm and access the conference link. The presentation materials will also be available on the company's website (http://www.kenseynash.com) beginning at 4:20 p.m. (ET) on Tuesday, May 13, 2008.

About Kensey Nash Corporation.

Kensey Nash Corporation is a leading medical technology company providing innovative solutions and technologies for a wide range of medical procedures. The Company provides an extensive range of products into multiple medical markets, primarily in the endovascular, sports medicine and spine markets. Many of the products are based on the Company's significant expertise in the design, development, manufacturing and processing of absorbable biomaterials, which has led to partnerships to commercialize technologies. Kensey Nash has also commercialized a series of innovative products through its own direct endovascular sales force. The Company is known as a pioneer in the field of arterial puncture closure, as the inventor and developer of the Angio-Seal(TM) Vascular Closure Device, which is licensed to St. Jude Medical, Inc.


'/>"/>
SOURCE Kensey Nash Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Corrected & Replaced - Natural Nutrition Expands Revenue Capabilities with Newly Installed State of the Art Nutrition Bar Line
2. Report Shows Millions May Be Driving with Uncorrected Visual Impairments
3. Fragile X Syndrome Corrected in Mice
4. CORRECTED: Hagens Berman Sobol Shapiro Files Suit Against Merck and Schering-Plough
5. Fluctuating eye pressure associated with visual field deterioration in glaucoma patients
6. Children of depressed moms do better when dad is involved, SLU researcher finds
7. Clinical depression linked to abnormal emotional brain circuits
8. Tumors use enzyme to recruit regulatory T-cells and suppress immune response
9. Specific antagonism lowers blood pressure
10. Are too many people diagnosed as depressed?
11. Depression Taking Toll on Returning U.S. Vets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... was developed to enhance the health of felines. The formula is all-natural and is ... herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus ...
(Date:6/26/2016)... , ... June 26, 2016 , ... ... once they have been diagnosed with endometriosis. These women need a treatment plan ... require a comprehensive approach that can help for preservation of fertility and ultimately ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... Austin residents ... the American College of Mohs Surgery and to Dr. Russell Peckham for medical and ... highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed ...
(Date:6/25/2016)... Viejo, California (PRWEB) , ... June 25, 2016 , ... ... to fit their specific project," said Christina Austin - CEO of Pixel Film Studios. ... fully customizable and all within Final Cut Pro X . Simply select a ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... As a ... Magna Cum Laude and his M.D from the David Geffen School of Medicine at ... returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Research and Markets has announced the addition of the ... offering. The current unmet ... for MedImmune to enter. The US ageing population creates a ... considerable growth for effective anti-influenza medications. The introduction of a ... development is still in its infancy. Key ...
(Date:6/23/2016)... and BOGOTA, Colombia , June 23, 2016  Astellas today announced the establishment of Astellas Farma ... as the company,s second affiliate in Latin America . ... ... Astellas Farma Colombia ... ...
(Date:6/23/2016)... 2016 Research and Markets has ... Global Analysis (United States, China, Japan, Brazil, United Kingdom, ... their offering. Surgical ... business planners, provides surgical procedure volume data in a ... an in-depth analysis of growth drivers and inhibitors, including ...
Breaking Medicine Technology: